Abstract
To report the impact on target volume delineation and dose to normal tissue using anatomic versus biological imaging (18 F-FDG-PET) for bone metastases. Patients with uncomplicated painful bone metastases were randomized (1:1:1) and blinded to receive either 8Gy in a single fraction with conventionally planned radiotherapy (ConvRT-8Gy) or 8Gy in a single fraction with dose-painting-by-numbers (DPBN) dose range between 6 and 10Gy) (DPBN-8Gy) or 16Gy in a single fraction with DPBN (dose range between 14 and 18Gy) (DPBN-16Gy). The primary endpoint was overall pain response at 1month. Volumes of the gross tumour volume (GTV) - both biological (GTVPET ) and anatomical (GTVCT ) -, planning target volume (PTV), dose to thenormal tissue and maximum standardized-uptake values (SUVMAX ) were analysed (secondary endpoint). Sixty-three percent of the GTVCT volume did not show 18 F-FDG-uptake. On average, 20% of the GTVPET volume was outside GTVCT . The volume of normal tissue receiving 4Gy, 6Gy and 8Gy was at least 3×, 6× and 13× smaller in DPBN-8Gy compared to ConvRT-8Gy and DPBN-16Gy (P<0.05). Positron emitting tomography-information potentially changes the target volume for bone metastases. DPBN between 6 and 10Gy significantly decreases dose to the normal tissue compared to conventional radiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
